日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid Tumors.

Copanlisib 与 Nivolumab 联合治疗晚期实体瘤患者的安全性和有效性:一项 Ib 期研究

Carneiro Benedito A, Jotte Robert M, Gabrail Nashat Y, Wentzel Kristopher, Huang Funan, Chaturvedi Shalini, Weispfenning Anke, Hiemeyer Florian, Morcos Peter N, Mongay Soler Lidia, Childs Barrett H, Hansen Aaron R

Exploratory biomarker analysis from a phase III study of the PI3K inhibitor, copanlisib, in combination with rituximab in patients with indolent non-Hodgkin lymphoma, a retrospective study

一项回顾性研究对PI3K抑制剂copanlisib联合利妥昔单抗治疗惰性非霍奇金淋巴瘤患者的III期研究进行了探索性生物标志物分析。

Chaturvedi, Shalini; Weispfenning, Anke; Descamps, Tine; Bellinvia, Sara; Bauer, David; Du, Rong; Lunt, Teresa; Soler, Lidia Mongay; Childs, Barrett H; Zinzani, Pier Luigi

Correction: Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma

更正:copanlisib单药治疗分子分型明确的复发或难治性弥漫性大B细胞淋巴瘤患者的磷脂酰肌醇3-激酶抑制活性

Lenz, Georg; Hawkes, Eliza; Verhoef, Gregor; Haioun, Corinne; Thye Lim, Soon; Seog Heo, Dae; Ardeshna, Kirit; Chong, Geoffrey; Haaber, Jacob; Shi, Wei; Gorbatchevsky, Igor; Lippert, Susanne; Hiemeyer, Florian; Piraino, Paolo; Beckmann, Georg; Peña, Carol; Buvaylo, Viktoriya; Childs, Barrett H; Salles, Gilles

CHRONOS-4: phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma

CHRONOS-4:一项评估copanlisib联合利妥昔单抗免疫化疗治疗复发性惰性B细胞淋巴瘤的3期研究

Zinzani, Pier Luigi; Wang, Huaqing; Feng, Jifeng; Kim, Tae Min; Tao, Rong; Zhang, Huilai; Fogliatto, Laura; Maluquer Artigal, Clara; Özcan, Muhit; Yanez, Eduardo; Kim, Won Seog; Kirtbaya, Dmitry; Kriachok, Iryna; Maciel, Felipe; Xue, Hongwei; Bouabdallah, Krimo; Phelps, Charles; Chaturvedi, Shalini; Weispfenning, Anke; Morcos, Peter N; Odongo, Fatuma; Buvaylo, Viktoriya; Childs, Barrett H; Dreyling, Martin; Matasar, Matthew; Ghione, Paola

Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study

抗间皮素抗体药物偶联物anetumab ravtansine联合聚乙二醇化脂质体阿霉素治疗铂耐药卵巢癌的安全性和活性:一项多中心、Ib期剂量递增和扩展研究

Santin, Alessandro D; Vergote, Ignace; González-Martín, Antonio; Moore, Kathleen; Oaknin, Ana; Romero, Ignacio; Diab, Sami; Copeland, Larry J; Monk, Bradley J; Coleman, Robert L; Herzog, Thomas J; Siegel, Jonathan; Kasten, Linda; Schlicker, Andreas; Schulz, Anke; Köchert, Karl; Walter, Annette O; Childs, Barrett H; Elbi, Cem; Bulat, Iurie

Model-informed approach to support pediatric dosing for the pan-PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors

基于模型的方法支持泛PI3K抑制剂copanlisib在复发/难治性实体瘤儿童和青少年中的儿科给药方案

Morcos, Peter N; Schlender, Jan; Burghaus, Rolf; Moss, Jonathan; Lloyd, Adam; Childs, Barrett H; Macy, Margaret E; Reid, Joel M; Chung, John; Garmann, Dirk

Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study

copanlisib治疗日本复发/难治性惰性非霍奇金淋巴瘤患者的安全性和抗肿瘤活性:一项Ib/II期研究

Fukuhara, Noriko; Maruyama, Dai; Hatake, Kiyohiko; Nagai, Hirokazu; Makita, Shinichi; Kamezaki, Kenjiro; Uchida, Toshiki; Kusumoto, Shigeru; Kuroda, Junya; Iriyama, Chisako; Yanada, Masamitsu; Tsukamoto, Norifumi; Suehiro, Youko; Minami, Hironobu; Garcia-Vargas, Jose; Childs, Barrett H; Yasuda, Masanobu; Masuda, Shigeo; Tsujino, Toshiaki; Terao, Yui; Tobinai, Kensei

Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial

安奈妥单抗拉坦辛与长春瑞滨治疗复发性间皮素阳性恶性胸膜间皮瘤(ARCS-M)患者的疗效比较:一项随机、开放标签的II期试验

Kindler, Hedy L; Novello, Silvia; Bearz, Alessandra; Ceresoli, Giovanni L; Aerts, Joachim G J V; Spicer, James; Taylor, Paul; Nackaerts, Kristiaan; Greystoke, Alastair; Jennens, Ross; Calabrò, Luana; Burgers, Jacobus A; Santoro, Armando; Cedrés, Susana; Serwatowski, Piotr; Ponce, Santiago; Van Meerbeeck, Jan P; Nowak, Anna K; Blumenschein, George Jr; Siegel, Jonathan M; Kasten, Linda; Köchert, Karl; Walter, Annette O; Childs, Barrett H; Elbi, Cem; Hassan, Raffit; Fennell, Dean A

Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma

copanlisib治疗复发或难治性边缘区淋巴瘤患者的疗效和安全性

Panayiotidis, Panayiotis; Follows, George A; Mollica, Luigina; Nagler, Arnon; Özcan, Muhit; Santoro, Armando; Stevens, Don; Trevarthen, David; Hiemeyer, Florian; Garcia-Vargas, Jose; Childs, Barrett H; Zinzani, Pier Luigi; Dreyling, Martin

Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma

在复发性惰性B细胞淋巴瘤患者中,磷脂酰肌醇3-激酶抑制剂Copanlisib与利妥昔单抗为基础的免疫化疗联合应用的可行性研究

Matasar, Matthew J; Dreyling, Martin; Leppä, Sirpa; Santoro, Armando; Pedersen, Michael; Buvaylo, Viktoriya; Fletcher, Monique; Childs, Barrett H; Zinzani, Pier Luigi